Mitochondrial disease
Gene: PTCD3
Three additional families reported.Created: 1 Sep 2023, 9:36 a.m. | Last Modified: 1 Sep 2023, 9:36 a.m.
Panel Version: 0.887
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Combined oxidative phosphorylation deficiency-51, MIM#619057
Publications
One compound heterozygote case and functional assays. Essential subunit of oxidative phosphorylation (OXPHOS) complexes.
Sources: NHS GMSCreated: 22 Mar 2020, 1:39 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Mental retardation; optic atrophy; Leigh-like syndrome
Publications
Publications for gene: PTCD3 were set to 30607703; 19427859
Gene: ptcd3 has been classified as Green List (High Evidence).
Phenotypes for gene: PTCD3 were changed from Mental retardation; optic atrophy; Leigh-like syndrome to Combined oxidative phosphorylation deficiency-51, MIM#619057; Mental retardation; optic atrophy; Leigh-like syndrome
Gene: ptcd3 has been classified as Amber List (Moderate Evidence).
Gene: ptcd3 has been classified as Amber List (Moderate Evidence).
gene: PTCD3 was added gene: PTCD3 was added to Mitochondrial disease. Sources: NHS GMS Mode of inheritance for gene: PTCD3 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: PTCD3 were set to 30607703; 19427859 Phenotypes for gene: PTCD3 were set to Mental retardation; optic atrophy; Leigh-like syndrome Review for gene: PTCD3 was set to AMBER